Difference between revisions of "Category:5 alpha-reductase inhibitors"
Jump to navigation
Jump to search
(Created page with "A class of medications that inhibit the enzyme 5α-reductase. This prevents the conversion of testosterone to DHT, and has potential efficacy as part of a treatment regimen fo...") |
m |
||
| Line 1: | Line 1: | ||
A class of medications that inhibit the enzyme 5α-reductase. This prevents the conversion of testosterone to DHT, and has potential efficacy as part of a treatment regimen for [[prostate cancer]]. | A class of medications that inhibit the enzyme 5α-reductase. This prevents the conversion of testosterone to DHT, and has potential efficacy as part of a treatment regimen for [[prostate cancer]]. | ||
| + | |||
| + | [[Category:Endocrine therapy]] | ||
Revision as of 19:34, 19 July 2017
A class of medications that inhibit the enzyme 5α-reductase. This prevents the conversion of testosterone to DHT, and has potential efficacy as part of a treatment regimen for prostate cancer.
Pages in category "5 alpha-reductase inhibitors"
The following 2 pages are in this category, out of 2 total.